Hot Features
Registrieren Sie sich kostenlos, um Echtzeitkurse, interaktive Charts, Live-Optionsfluss und mehr zu erhalten.
Consolidates ownership of listeria monocytogenes-based immunotherapy IP Eliminates milestone payments and reduces future royalty obligations relating to OST-HER2 for osteosarcoma and other...
Consolidates ownership of listeria monocytogenes-based immunotherapy IP Eliminates milestone payments and reduces future royalty obligations relating to OST-HER2 for osteosarcoma and other...
The primary endpoint of 12-month Event Free Survival (EFS) for OST-HER2- treated patients (33.3%) was statistically significant (p= 0.0158) when compared with peer-reviewed comparable historical...
The primary endpoint of 12-month Event Free Survival (EFS) for OST-HER2- treated patients (33.3%) was statistically significant (p= 0.0158) when compared with peer-reviewed comparable historical...
| Zeitraum † | Änderung | Änderung % | Handelsbeginn | Hoch | Niedrig | Durchsch. Volumen | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | -0.89 | -30.7958477509 | 2.89 | 3.53 | 1.95 | 252456 | 2.5886779 | CS |
| 4 | -2.34 | -53.9170506912 | 4.34 | 7 | 1.95 | 1384396 | 4.1374563 | CS |
| 12 | -0.8 | -28.5714285714 | 2.8 | 7 | 1.58 | 491697 | 4.08625213 | CS |
| 26 | -2 | -50 | 4 | 7 | 1.58 | 300263 | 3.9879873 | CS |
| 52 | -2 | -50 | 4 | 7 | 1.58 | 300263 | 3.9879873 | CS |
| 156 | -2 | -50 | 4 | 7 | 1.58 | 300263 | 3.9879873 | CS |
| 260 | -2 | -50 | 4 | 7 | 1.58 | 300263 | 3.9879873 | CS |
| Symbol | Preis | Vol. |
|---|---|---|
| TSLZT Rex 2X Inverse Tesla Daily Target ETF | US$ 2,3325 (-7,26%) | 91,03M |
| SOXLDirexion Daily Semiconductor Bull 3X Shares | US$ 27,06 (5,37%) | 57,42M |
| NVDQT Rex 2X Inverse NVIDIA Daily Target ETF | US$ 3,5499 (5,65%) | 57,04M |
| XLFFinancial Select Sector | US$ 52,00 (1,40%) | 43,65M |
| SPXSDirexion Daily S&P 500 Bear 3X Shares New | US$ 5,745 (-1,29%) | 40,28M |
| Keine Diskussionen Gefunden. |
| Neuen Thread Erstellen |
Die zuletzt besuchten Aktien werden in diesem Feld angezeigt, so dass Sie leicht zu den Aktien zurückkehren können, die Sie zuvor angesehen haben.
Support: +44 (0) 203 8794 460 | support@advfn.de
Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen
Premium
